Impacting Pipelines and Bottom Lines – Learn More About Partnering with NCI

The Spring Meeting of the Oncology Investor Conference will be held virtually from March 29th through April 2, 2021. This meeting is a great event for investors seeking to invest in private and public cancer opportunities. If you are interested in learning about how to partner or collaborate with the National Cancer Institute (NCI), this is a great opportunity.

On Wednesday, March 31st NCI’s Dr. Michael Salgaller and the NIH Office of Technology Transfer (OTT)’s Steven Ferguson will be speaking at 9am on how having NCI as a technology development and commercialization partner can impact pipelines and bottom lines. Salgaller leads the Invention Development and Marketing Unit (IDMU) within the Technology Transfer Center at NCI. He has over 20 years of scientific and investment experience and is ready to help foster licensing and collaboration activities between your organization and NCI. Ferguson is a Special Advisor at OTT and brings 30+ years of experience on how to set up successful partnerships with NIH and utilize a variety of available opportunities for your own company.

If you are interested in attending, please register here.